儿童白塞综合征45例临床特征分析

魏晨曦, 智树凤, 蒋丽君, 赵雪, 苏庆晓, 齐兴杰, 戎赞华

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1253-1258.

PDF(574 KB)
HTML
PDF(574 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (10) : 1253-1258. DOI: 10.7499/j.issn.1008-8830.2503178
论著·临床研究

儿童白塞综合征45例临床特征分析

作者信息 +

Clinical characteristics of Behçet syndrome in 45 children

Author information +
文章历史 +

摘要

目的 探讨儿童白塞综合征(Behçet syndrome, BS)的临床特征,为儿童BS的诊治提供参考。 方法 回顾性分析2014年12月—2024年12月于河北医科大学第二医院儿科住院且符合BS诊断标准患儿的临床资料。 结果 45例BS患儿中,男性26例(58%),临床表现以口腔溃疡最常见(43例,96%),其余包括生殖器溃疡23例(51%),消化系统受累18例(40%)等。生殖器溃疡女性多见,眼部病变男性多见(P<0.05)。针刺试验阳性10例(22%),人类白细胞抗原-B51阳性13例(29%)。粪便钙卫蛋白(fecal calprotectin, FC)升高16例(36%),FC升高患儿消化系统受累比例高于FC正常患儿(P<0.05)。符合1990年白塞病国际研究组诊断标准17例(38%),2014年白塞病国际评分标准33例(73%),2015年儿童白塞病诊断标准13例(29%)。 结论 儿童BS临床表现异质性强,人类白细胞抗原-B51与其发病相关。

Abstract

Objective To study the clinical characteristics of pediatric Behçet syndrome (BS). Methods A retrospective review was conducted on the medical records of children hospitalized in the Department of Pediatrics at the Second Hospital of Hebei Medical University between December 2014 and December 2024 who met diagnostic criteria for BS. Results Among 45 children with BS, 26 (58%) were male. Oral aphthous ulcers were the most common manifestation (43/45, 96%), followed by genital ulcers (23/45, 51%) and gastrointestinal involvement (18/45, 40%). Genital ulcers were more frequent in girls, whereas ocular involvement was more common in boys (P<0.05). The pathergy test was positive in 10 (22%), and HLA-B51 was positive in 13 (29%). Fecal calprotectin (FC) was elevated in 16 (36%); gastrointestinal involvement was more frequent in children with elevated FC than in those with normal FC (P<0.05). According to the respective criteria, 17 (38%) patients met the International Study Group criteria (1990), 33 (73%) met the International Criteria for Behçet Disease (2014), and 13 (29%) met the Pediatric Behçet Disease criteria (2015). Conclusions Pediatric BS shows marked clinical heterogeneity. HLA-B51 is associated with disease susceptibility.

关键词

白塞综合征 / 临床特征 / 粪便钙卫蛋白 / 人类白细胞抗原-B51 / 儿童

Key words

Behçet syndrome / Clinical characteristic / Fecal calprotectin / HLA-B51 / Child

引用本文

导出引用
魏晨曦, 智树凤, 蒋丽君, . 儿童白塞综合征45例临床特征分析[J]. 中国当代儿科杂志. 2025, 27(10): 1253-1258 https://doi.org/10.7499/j.issn.1008-8830.2503178
Chen-Xi WEI, Shu-Feng ZHI, Li-Jun JIANG, et al. Clinical characteristics of Behçet syndrome in 45 children[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(10): 1253-1258 https://doi.org/10.7499/j.issn.1008-8830.2503178

参考文献

[1]
Alibaz-Oner F, Direskeneli H. Update on the diagnosis of Behçet's disease[J]. Diagnostics (Basel), 2022, 13(1): 41. PMCID: PMC9818538. DOI: 10.3390/diagnostics13010041 .
[2]
International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria[J]. J Eur Acad Dermatol Venereol, 2014, 28(3): 338-347. DOI: 10.1111/jdv.12107 .
[3]
Rapo M, Molander P, af Björkesten CG, et al. Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease[J]. Int J Colorectal Dis, 2025, 40(1): 45. PMCID: PMC11836091. DOI: 10.1007/s00384-025-04829-6 .
[4]
Hayashida M, Miyoshi J, Mitsui T, et al. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease[J]. J Gastroenterol Hepatol, 2020, 35(8): 1340-1346. DOI: 10.1111/jgh.14995 .
[5]
Kurt T, Aydın F, Sezer M, et al. Performance of diagnostic criteria in pediatric Behçet's disease[J]. Rheumatol Int, 2022, 42(1): 127-132. DOI: 10.1007/s00296-020-04777-0 .
[6]
Lee BH, Chung KB, Jang H, et al. HLA-B51 positivity correlates with symptom completeness from recurrent aphthous stomatitis to complete Behçet's disease[J]. J Dermatol, 2025, 52(6): 1001-1007. PMCID: PMC12149367. DOI: 10.1111/1346-8138.17748 .
[7]
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease[J]. Lancet, 1990, 335(8697): 1078-1080.
[8]
Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD[J]. Ann Rheum Dis, 2016, 75(6): 958-964. DOI: 10.1136/annrheumdis-2015-208491 .
[9]
Burns E, Cooper E, Peterson R, et al. Pediatric Behҫet disease: update in diagnosis and management[J]. Pediatr Dermatol, 2022, 39(2): 173-181. DOI: 10.1111/pde.14859 .
[10]
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159. DOI: 10.1136/annrheumdis-2018-214819 .
[11]
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017, 69(1): 35-45. PMCID: PMC5650478. DOI: 10.1002/art.39859 .
[12]
Fazaa A, Makhlouf Y, Ben Massoud F, et al. Behçet disease: epidemiology, classification criteria and treatment modalities[J]. Expert Rev Clin Immunol, 2024, 20(12): 1437-1448. DOI: 10.1080/1744666X.2024.2388693 .
[13]
Hu D, She CH, Bao HF, et al. Clinical heterogeneity and five phenotypes identified in pediatric Behçet's syndrome: a cohort study from Shanghai Behçet's syndrome database[J]. World J Pediatr, 2024, 20(8): 801-808. PMCID: PMC11402839. DOI: 10.1007/s12519-023-00785-9 .
[14]
Zou J, Luo JF, Shen Y, et al. Distinct clinical characteristics of pediatric Behçet's syndrome: a study from a referral center in China[J]. Mod Rheumatol, 2021, 31(6): 1158-1163. DOI: 10.1080/14397595.2021.1891670 .
[15]
Hoseini Z, Rad FR, Zarei M, et al. HLA-B*51:01 in Iranian patients with Behcet uveitis syndrome[J]. Reumatol Clin (Engl Ed), 2024, 20(9): 470-475. DOI: 10.1016/j.reumae.2024.07.011 .
[16]
Santangelo A, Corsello A, Gizzi G, et al. Exploring headaches in pediatric Behçet disease: prevalence, clinical impact, and management[J]. J Clin Med, 2024, 13(13): 3659. PMCID: PMC11242365. DOI: 10.3390/jcm13133659 .
[17]
王莲, 闫淯淳, 王艺霖, 等. 儿童神经白塞综合征5例的临床特征及预后分析[J]. 中华儿科杂志, 2025, 63(1):80-83. DOI: 10.3760/cma.j.cn112140-20240810-00568 .
[18]
She CH, Cai JF, Hu D, et al. Clinical characteristics of Behçet's syndrome in Shanghai database: baseline data of a cross-sectional cohort study[J]. Int J Rheum Dis, 2024, 27(10): e15355. DOI: 10.1111/1756-185X.15355 .
[19]
Kurt T, Aydın F, Sezer M, et al. Performance of diagnostic criteria in pediatric Behçet's disease[J]. Rheumatol Int, 2022, 42(1): 127-132. DOI: 10.1007/s00296-020-04777-0 .
[20]
Lv Q, Li Y, Wei Q, et al. Autoinflammatory syndromes mimicking Behçet's disease with gastrointestinal involvement: a retrospective analysis[J]. Clin Exp Rheumatol, 2024, 42(10): 2076-2085. DOI: 10.55563/clinexprheumatol/g6729b .
[21]
Manuelyan Z, Butt E, Parupudi S. Gastrointestinal Behçet's disease: manifestations, diagnosis, and management[J]. Dis Mon, 2024, 70(1S): 101674. DOI: 10.1016/j.disamonth.2023.101674 .
[22]
葛均波, 徐永健, 王辰. 内科学[M]. 9版. 北京: 人民卫生出版社, 2018: 843-846.

脚注

所有作者均声明无利益冲突。


编委: 王颖

版权

版权所有 © 2023中国当代儿科杂志
PDF(574 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/